Show simple item record

dc.contributor.authorAnywar, Godwin
dc.date.accessioned2021-12-10T12:25:56Z
dc.date.available2021-12-10T12:25:56Z
dc.date.issued2021-11-07
dc.identifier.urihttp://hdl.handle.net/10570/9148
dc.descriptionA thesis submitted to the Directorate of Research and Graduate Training for the award of the Degree Of Doctor of Philosophy of Makerere Universityen_US
dc.description.abstractOpportunistic infections (OI) are the single most important cause of mortality and morbidity among PLHIV in poor countries. There is widespread use of medicinal plants among PLHIV. However, there is no scientific information and validation on their toxicity, safety and efficacy. The aim of this study was to document and evaluate the cytotoxicity, anti-HIV-1 and immunomodulatory activities of medicinal plant species used by herbalists in treating PLHIV in Uganda. An ethnopharmacological survey was conducted in Arua, Dokolo, Mbale, Bushenyi, Iganga, Rakai, Luwero and Kaabong districts. Ninety herbalists were interviewed using semi-structured questionnaires. The in vitro cytotoxicity of 11 plant species was determined with the AlamarBlue cell viability assay on the human glioblastoma cell line: U87.CD4.CXCR4. Warburgia ugandensis, Erythrina abyssinica, Cryptolepsis sanguinolenta, Albizia coriaria, Psorospermum febrifugum, Maytenus senegalensis (Sny: Gymnosporia senegalensis), Zanthoxylum chalybeum, Securidaca longipendunculata, Acacia hockii, Gardenia ternifolia Subsp. jovis-tonantis and Bridelia micrantha were screened. Two hundred and thirty-six medicinal plant species from 70 families were documented. There is a high degree of consensus among the TMP on which plant species they use. The herbalists encourage the concomitant use of herbs and ARV and relied on laboratory diagnoses for confirmation of ones sero-status even though they were familiar with the signs and symptoms of HIV/AIDS. The half maximal cytotoxic concentration (CC50) of the extracts was determined. Each plant species had two extracts, DMSO ethanol. The crude plant extracts were tested for antiviral activity against HIV-1 Pseudovirions (PV), HXB2 (IIIB) strain using U87.CD4.CXCR4 cells transfected with the luciferase firefly reporter gene and measured using a luminometer. The selective inhibition of HIV-1 PV was determined using the Selectivity Index (SI). The immunomodulatory effects of the plant extracts were examined using Flow cytometry. The plant extracts were screened for cytotoxicity using the live/dead assay with Peripheral Mononuclear Blood Cells (PMBCs) and for their cytokine inducing activity on IL-2, IL-4, IFN-γ and TNF-α. The plant extracts were also investigated for their cell-proliferation activity. Using regression analysis, exponential curves of fit were drawn in Microsoft Excel 2011. The 50% cytotoxicity values (CC50) of the plant extracts and the coefficient of determination, R2 were calculated. Both the ethanol and DMSO extracts of W. ugandensis (CC50 = 7.6 and 1.5 µg/ml) and A. coriria (CC50 = 6.4 and < 4 µg/ml) were highly cytotoxic. Most of the plant extracts (15/22) were moderately cytotoxic (CC50 = 21-200 µg/ml). The ethanol extracts were generally less toxic than the DMSO extracts. The ethanol extract of P. febrifugum exhibited the highest selective antiviral activity against HIV-1 (SI = 165.8, CC50 = 99.45 µg/ml) with no cytotoxicity at 8 µg/ml. Both the ethanol and DMSO extracts of A. coriaria (CC50 of 6.4 and < 4 µg/ml) and W. ugandensis (7.6 and 1.5 µg/ml) were highly cytotoxic. The flow cytometry results were presented using dot plots. Non-toxic concentrations of the extracts from the live/dead assay ranged from 0.1 µg/ml for W. ugandensis to 30 µg/ml for A. hockii, A. coriaria, B. micrantha, C. sanguinolenta and Z. chalybeaum. The ethanol extract of P. febrifugum stimulated TNF-α and Z. chalybeaum and W. ugandensis stimulated IL-4. None of the extracts showed an effect on T-cell proliferation. In Conclusion, there is wide spread use of medicinal plant species to manage OI and boost immunity in PLHIV in Uganda.en_US
dc.description.sponsorshipThis research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Centre and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No--B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK governmenten_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectMedicinal plants; herbalists; Traditional Medicine Practitioners; opportunistic infections; HIV/AIDS; Cytotoxicity; Antiviral; Anti-HIV-1; immunomodulatory; cytokines; Uganda.en_US
dc.subjectMedicinal plantsen_US
dc.subjectHerbalistsen_US
dc.subjectTraditional Medicine Practitionersen_US
dc.subjectOpportunistic infectionsen_US
dc.subjectHIV/AIDSen_US
dc.subjectCytotoxicityen_US
dc.subjectAntiviral; Anti-HIV-1en_US
dc.subjectimmunomodulatoryen_US
dc.subjectCytokinesen_US
dc.subjectUgandaen_US
dc.titleEthnopharmacology, cytotoxicity, antiviral and immunomodulatory profiles of medicinal plant species used by herbalists in treating people living with HIV/AIDS in Ugandaen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record